FaceYa FaceYa
搜尋結果
查看所有結果
  • 加入
    登入
    註冊
    搜索
    主題切換器
    夜晚模式

搜索

發現新朋友並建立連結

  • 最新消息
  • 探索
  • 頁面
  • 群組
  • 活動
  • 部落格
  • 優惠
  • 工作
  • 課程
  • 論壇
  • 電影
  • 遊戲
  • 文章
  • 部落格
  • 使用者
  • 頁面
  • 群組
  • 活動
  • Wang Judy 添加的博客 其他
    2026-05-14 06:29:15 -
    GC Biotech’s Role in High-Performance Immune Potentiating Adjuvant Development
    In vaccine development and immunotherapy, one of the most critical challenges is not only delivering an antigen, but ensuring the immune system responds to it in a strong, controlled, and durable way. In many cases, antigens alone are not sufficient to trigger an optimal immune response. This is where immune potentiating adjuvants play a central role. Immune potentiating adjuvants are...
    0 发布评论计数 0 分享 666 查看 0 評論
    請登入後使用 點讚,分享和評論功能!
  • Wang Judy 添加的博客 其他
    2026-05-28 08:09:27 -
    New Application Scenarios for the AS01 Adjuvant: The ACI-24.060 Alzheimer’s Disease Vaccine Project
    The treatment of Alzheimer’s Disease (AD) has entered the era of "Disease-Modifying Therapies" (DMTs). With the approval of anti-Aβ monoclonal antibodies (such as Lecanemab), the Amyloid Cascade Hypothesis has received clinical validation. However, the safety risks associated with ARIA (Amyloid-Related Imaging Abnormalities) in monoclonal antibody therapies, as well as their high...
    0 发布评论计数 0 分享 292 查看 0 評論
    請登入後使用 點讚,分享和評論功能!
  • Wang Judy 添加的博客 其他
    2026-06-10 06:59:58 -
    The Potential and Advantages of Using the AS01 Adjuvant in Next-Generation Adjuvanted Influenza Vaccines
    Influenza vaccines represent one of the largest segments of the global vaccine market (with the global market size exceeding $8 billion by 2025). However, the protective efficacy of traditional split-virus vaccines has long hovered between 30% and 50% among individuals aged 65 and older and immunocompromised populations. Additionally, these vaccines require annual updates, offer short-term...
    0 发布评论计数 0 分享 6 查看 0 評論
    請登入後使用 點讚,分享和評論功能!
  • Wang Judy 添加的博客 其他
    2026-04-10 02:57:04 -
    【Dual Exhibition Tour】GC Biotech's June Roadshow: Veterinary Adjuvant Innovation × Human Vaccine Breakthrough – Dual Tracks Driving the Future of Immunity
    This June, GC Biotech will participate in two major industry exhibitions in China, bringing together the latest innovations in veterinary drugs, vaccine adjuvants, and pharmaceutical technologies. These events provide an important platform for global collaboration, technological exchange, and industry advancement. We sincerely invite partners and industry professionals to visit us, explore new...
    0 发布评论计数 0 分享 833 查看 0 評論
    請登入後使用 點讚,分享和評論功能!
© 2026 FaceYa 繁体中文
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek 简体中文 日本語 한국어 繁体中文
关于: 條款 隱私權 聯絡我們 目錄